Clinical Trials Logo
  1. Home
  2. Breast Cancer
  3. NCT03578627
  4. Details
NCT03578627 Clinical Trial

Stress and Immunity Breast Cancer Project

Breast Cancer Stage II Clinical Trial

Official title:
Psychological/Immunity Studies With Women With Cancer Previously

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03578627
Other study ID # 1992C0350
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 1994
Est. completion date May 31, 2000

Study information
Verified date July 2018
Source Ohio State University Comprehensive Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

An investigative study of the effectiveness of the BioBehavioral Intervention on Stage II/III breast cancer patients. A total of 231 patients were split between an assessment-only control group and an experimental group receiving the Intervention and assessment. The goal of the Intervention is to use psychological, behavioral, and biologic methods with the primary goal of reducing cancer recurrence.

Recruitment information / eligibility
Status Completed
Enrollment 231
Est. completion date May 31, 2000
Est. primary completion date May 31, 2000
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Stage II or III breast cancer diagnosis prior to adjuvant therapy

Exclusion Criteria:

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• BioBehavioral Intervention
Psychological (stress and quality of life), behavioral (health behaviors and compliance), and biologic (neuroendocrine and immune) factors, and pathways by which health outcomes (e.g. disease endpoints—recurrence, disease free interval) might be affected.

Locations
Country Name City State
United States Ohio State University Medical Center Columbus Ohio

Sponsors (1)
Lead Sponsor Collaborator
Ohio State University Comprehensive Cancer Center

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Recurrence event Diagnosis of pathologically confirmed breast cancer recurrence Ten years
Primary Recurrence time Time from the day of initial stage II or III breast cancer diagnosis to day of pathology confirmed breast cancer recurrence Ten years
See also
  Status Clinical Trial Phase
Recruiting NCT05528263 - Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial) N/A
Recruiting NCT03270072 - The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients
Terminated NCT03723863 - Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy N/A
Completed NCT00393341 - Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer N/A
Recruiting NCT05558722 - Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer Phase 2
Active, not recruiting NCT04180579 - Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients N/A
Recruiting NCT03879577 - Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer Phase 2
Withdrawn NCT03058939 - Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer Phase 2
Recruiting NCT05877859 - Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
Recruiting NCT05296746 - Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer Phase 2
Withdrawn NCT05774886 - Implantable Microdevice for TNBC - Pilot Study Phase 1
Completed NCT01599039 - Study the Usefulness of Bio-impedance Spectroscopy in the Early Assessment of Breast Cancer Related Lymphoedema N/A
Unknown status NCT01352494 - Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer Phase 2
Recruiting NCT06275126 - Optimizing Surgical Decisions in Young Adults With Breast Cancer N/A
Not yet recruiting NCT05724758 - Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery
Active, not recruiting NCT03766009 - Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making N/A
Recruiting NCT05406531 - The Effectiveness of Psychological Interventions in Psycho-neuroendocrine-immune Network in Breast Cancer Survivors N/A
Active, not recruiting NCT03609047 - Adjuvant Palbociclib in Elderly Patients With Breast Cancer Phase 2
Recruiting NCT05898789 - Virtual Rehabilitation for Cancer Survivors N/A
Recruiting NCT06006806 - Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy N/A

External Links